Key Takeaways Illumina launches BioInsight to turn multiomic data into actionable insights for drug discovery and research.Rami Mehio appointed SVP & GM of BioInsight, joining Illumina's executive leadership team.ILMN's BioInsight drives multiomic research via large-scale initiatives and partner collaborations.Illumina, Inc. (ILMN) recently announced the launch of BioInsight, a new business unit developed to meet industry demand for deeper biologic insights, driven by the need of researchers and pharma comp ...

Accessibility StatementSkip Navigation BioInsight, a new business within Illumina, is launched with a dedicated focus on developing data assets, software, and AI solutions to fuel breakthroughs in life sciences. Rami Mehio, Senior Vice President and General Manager, BioSight at Illumina. New business focuses on developing data assets, software, and AI to fuel life science breakthroughs Expands pharma access to large omics datasets to advance target discovery and drug development SAN DIEGO, Oct. 1, 2025 /P ...